Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/26269
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Montanari, Carlos Alberto | - |
dc.contributor.author | Bolzani, Vanderlan da Silva | - |
dc.date.accessioned | 2014-05-20T14:20:53Z | - |
dc.date.accessioned | 2016-10-25T17:41:46Z | - |
dc.date.available | 2014-05-20T14:20:53Z | - |
dc.date.available | 2016-10-25T17:41:46Z | - |
dc.date.issued | 2001-02-01 | - |
dc.identifier | http://dx.doi.org/10.1590/S0100-40422001000100018 | - |
dc.identifier.citation | Química Nova. Sociedade Brasileira de Química, v. 24, n. 1, p. 105-111, 2001. | - |
dc.identifier.issn | 0100-4042 | - |
dc.identifier.uri | http://hdl.handle.net/11449/26269 | - |
dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/26269 | - |
dc.description.abstract | In the area of drug discovery, natural products represent a myriad of templates for new lead discovery. It is, however, most unlikely that the bioactive principle itself shall become a drug; it is much more likely that a medicinal chemistry project needs to be initiated as soon the potency or selectivity or specificity of the new natural product candidate has been disclosed. Brazil has an enormous biodiversity where just a few has been disclosed. Nevertheless, it urges to initiate a joint collaboration in order to circumvent a major breakdown linking between natural products and medicinal chemistry in this country. This paper is intended to encourage people to follow up one of the most pushing forward enterprise that needs to be settled: the pharmaceutical industry. | en |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | - |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | - |
dc.format.extent | 105-111 | - |
dc.language.iso | por | - |
dc.publisher | Sociedade Brasileira de Química | - |
dc.source | SciELO | - |
dc.subject | natural products | en |
dc.subject | medicinal chemistry | en |
dc.subject | pharmaceutical industry | en |
dc.title | Planejamento racional de fármacos baseado em produtos naturais | pt |
dc.title.alternative | Drug design based on natural products | en |
dc.type | outro | - |
dc.contributor.institution | Universidade Federal de Minas Gerais (UFMG) | - |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
dc.description.affiliation | Universidade Federal de Minas Gerais Departamento de Química | - |
dc.description.affiliation | Universidade Estadual Paulista Instituto de Química | - |
dc.description.affiliationUnesp | Universidade Estadual Paulista Instituto de Química | - |
dc.identifier.doi | 10.1590/S0100-40422001000100018 | - |
dc.identifier.scielo | S0100-40422001000100018 | - |
dc.rights.accessRights | Acesso aberto | - |
dc.identifier.file | S0100-40422001000100018.pdf | - |
dc.relation.ispartof | Química Nova | - |
Appears in Collections: | Artigos, TCCs, Teses e Dissertações da Unesp |
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.